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Clinical Guidelines Written by Residents
David W. Andrews, MD
Department of Neurological Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania 
Anticonvulsant use in brain tumor patients
Hugh Moulding, MD
More than 200,000 patients are diagnosed with primary or metastatic brain tumors each year in 
the United States. Of these patients, 20% to 40% will develop seizures at presentation, and another 
20% to 40% will require treatment for seizures during their illness. Although the use of antiepileptic 
drugs (AEDs) in patients who have had seizures seems reasonable, the issue of prophylactic AED 
use for patients who have not had a seizure is an intensely debated subject.
At TJUH, we see the wide variety of practices in prophylactic use of anticonvulsants.  Some physi-
cians will use anticonvulsants and follow therapeutic levels, others will use a starting dose of AED 
and not follow levels, and still others will not use AED at all.  The reason for the discrepancy is 
most likely multifactorial.  There is little evidence to the benefit of AEDs in patients who have not 
had seizures when considering the side effect profile of AEDs.  However, give the litigious climate 
of Philadelphia, many neurosurgeons are reluctant to leave a patient with an intracerebral lesion 
without antiepileptic coverage.  Additionally, many neurosurgeons are creatures of habit, trained 
to practice a certain way, and have done so for many years during which “it has worked or them so 
far.”  A set of guidelines based on a literature search, where level I evidence is cited where possible, 
would help physicians to be more comfortable about changing their practice.
“Variation” is an innocent word that that can represent many levels of frustration to the clinician.  Variation among patients is the least of these; 
the physician expects patients and their individual problems to be as diverse as the human race itself. Variation within a practice should be due 
to matching the specific needs of the specific patient. Other variations can mean trouble if they represent differences in understanding of the 
problem among clinicians and other allied health practitioners. These differences could be between institutions or even between shifts within 
one institution. 
The Tufts Health Care Institute (THCI) is a non-profit organization which provides educational tools for medical and surgical residents across 
the US. One of these tools teaches clinical practice guidelines, defined by the Institute of Medicine as “systematically developed statements to 
assist practitioner and patient decisions about appropriate health care for specific clinical circumstances.”1.  One of the authors of the Clinical 
Guidelines module is David B. Nash, Professor of Health Policy here at Thomas Jefferson University.
The Jefferson Department of Neurological Surgery has been participating in the THCI program for the past few years, mentored by Dr. David W. 
Andrews of the department. Because surgery and medicine have different emphases, Dr. Andrews has found that some of the THCI modules are 
more appropriate than others for the neurosurgical residents, and that the Clinical Guidelines module in particular has generated both enthusiasm 
and good results. A selection of the TJU neurosurgical resident-generated guidelines are presented here. These guidelines have not officially been 
adopted by the department or by any institution that we know of, but show how clinical problems can be identified and solved.
References
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Since 2000, there have been practive guidelines 
in place approved by the American Academy of 
Neurology (see Ref 3) based on peer reviewed 
publications with level I evidence. Despite these 
practice parameters a recent survey reported 
that 81% of neurosurgeons and 53% of neurol-
ogists prescribed antiepileptic drugs (AEDs) 
prophylactically.  
For the 20-40% of patients diagnosed with a 
brain tumor who have experienced a seizure, 
prophylactic use of AEDs is universally accepted. 
Seventy percent of brain tumor patients 
presenting with seizures will suffer recurrent 
seizures regardless of tumor type. However, 
patients that have not had a seizure still remain 
at risk and 20-45% will develop seizures.  Some 
factors that have been shown to increase the 
likelihood of developing seizures are: 
1.  Tumor location, most likely in frontal, 
parietal or temporal lobes, especially 
parasagital meningiomas (74% seizure 
prevalence). 
2.  Number of tumors: increased number of 
tumors correlates to higher seizure risk. 
3. Tumor histopathology: Slow growing 
tumors are at increased risk.  
4. Age: younger patients more likely to seize.  
One factor that is conspicuously absent from 
the list above is AED use. Of the twelve studies 
of Level I & II data that examined this question, 
only one reported a significant difference in 
seizure frequency and this favored the non-
AED group having a lower seizure risk. A 
meta-analysis performed on the four Level I 
studies showed an Odds Ratio of 1.09 with no 
statistical significance (p=0.9). Furthermore 
AED use is not benign; 23.8% of these patients 
experience side effects that warranted change 
or discontinuation of the AED. These side 
effects included rash (14%), nausea and 
vomiting (5%), encephalopathy (5%), and 
myelosuppression (3%). 
References
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Cervical spondylotic myelopathy
Amgad Hanna, MD
Cervical spondylotic myelopathy is a common 
cause of major morbidity in middle-aged and 
elderly people. Various functional classifica-
tions are used to evaluate patients with cervical 
spondylosis. They are based on pure clinical 
data, and are used as a method of evaluation of 
the patient’s progress during the course of the 
disease. None of these classifications defines 
criteria for the indication for surgery.
Patients with cervical myelopathy may be 
managed either conservatively or surgically. 
Conservative management includes medica-
tions (e..g, non-steroidal anti-inflammatories 
or corticosteroids), cervical orthotics, physical 
therapy, or injections. Surgery includes ante-
rior and/or posterior decompression and/or 
fusion.
There remains considerable uncertainty 
regarding the decision to operate and the 
timing for surgery. This is left to the surgeon’s 
discretion in most of the cases. Most surgeons 
would agree that patients with mild myelopa-
thy should be managed conservatively and 
patients with severe myelopathy should be 
managed surgically. There is a large gray zone 
of moderate myelopathy where surgeons may 
decide about surgery or conservative manage-
ment. The definition of mild, moderate, or 
severe myelopathy is vague in literature. 
The timing of surgery is also controversial 
in literature. Advocates of early surgery try 
to stop disease progression, prevent further 
clinical deterioration of the patients, and pre-
vent the risk of acute deterioration with neck 
injuries (central cord syndrome). Advocates 
of late surgery try to delay the potential 
complications of surgery like adjacent level 
disease, spinal cord injury, cerebrospinal fluid 
leak, infection, bleeding, and possible clinical 
deterioration.
We attempt to address the literature 
controversies regarding this topic, the severity 
of myelopathy, and the indications for surgery.
Online search for resources
National guideline clearinghouse. We 
searched for “cervical myelopathy”. No 
guidelines were found for the management 
of cervical myelopathy. Related guidelines 
were found for cervical radiculopathy: 
Review criteria for cervical surgery for 
entrapment of a single nerve root. Olympia 
(WA): Washington State Department of 
Labor and Industries; 2004 June. 1p. The 
article states that “Cases of myelopathy 
should be referred for physician review”.
The Cochrane Library. We searched for “cer-
vical myelopathy”. One article was found: 
Cochrane review on the role of surgery in 
cervical spondylotic radiculomyelopathy. 
Fouyas I, Statham P, Sandercock P. Spine 
2002; 27 (7): 736-47
Medline search: www.ncbi.nlm.nih.gov. 
We searched for “management of cervical 
myelopathy”; 104 articles were found
Summary of findings
There are no current guidelines for the man-
agement of cervical spondylotic myelopathy. 
Several articles (1,2) discussed the prognostic 
factors and presented surgical outcomes. These 
articles presented conflicting results as far as 
the prognostic significance of signal changes 
on MRI, age, and duration of symptoms.
Other studies discussed the indications and 
outcomes of different surgical approaches. 
Again, conflicting results were found. Fouyas 
et al. found no significant longterm differences 
between surgery and conservative manage-
ment3. Houten, Kim, Medow, Komotar, and 
Sekhon showed good results with surgical 
decompression 2, 4-7. However, there was no 
comparison to conservative management.
Guidelines
The two articles selected are references 2 and 3. 
Reference : Houten, Cooper (00)
Full reference: Laminectomy and posterior cer-
vical plating for multilevel cervical spondylotic 
myelopathy and ossification of the posterior 
longitudinal ligament: effects on cervical align-
ment, spinal cord compression, and neurologi-
cal outcome. Houten J, Cooper P. Neurosurgery 
2003; 52 (5): 1081-8
1.
2.
3.
Resident Education
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Results 
Multilevel cervical laminectomy and 
fusion for cervical spondylotic myelopa-
thy provide minimal morbidity, excel-
lent decompression, immediate stability, 
prevent kyphosis, and precludes further 
spondylosis.
Strengths
Combined clinical and radiological crite-
ria for outcome after surgery.
Thirty months follow up.
Weaknesses
Retrospective study. 
Small number of patients (38).
No comparison group with conservative 
management. 
No consideration for bony fusion vs 
pseudoarthrosis.
Reference : Fouyas, Statham, Sandercock 
(00)
Full reference: Cochrane review on the role of 
surgery in cervical spondylotic radiculomy-
elopathy. Fouyas I, Statham P, Sandercock P. 
Spine 2002; 27 (7): 736-47
Results
No significant difference in long term out-
come between surgical and conservative 
management for cervical myelopathy.
Strengths
Prospective randomized trials.
Weaknesses
Patients represented in the studies had 
mainly mild functional deficit. They do 
not represent the population that usually 
benefits from surgery, who have moder-
ate to severe myelopathy.
-
-
-
-
-
-
-
-
-
-
Final Guideline   
This guideline targets mainly neurosurgeons 
and orthopedic spine surgeons who need to 
decide for their patients whether to proceed 
with surgical or conservative management. It 
also targets primary care physicians to guide 
them as to which patients need to be referred 
for surgery. 
Evaluation of the severity of myelopathy:
The following scoring system is proposed to 
evaluate the severity of cervical myelopathy:
Comments
This is the first grading system to include 
both clinical and radiological data.
Mild to moderate symptoms: mild pain or 
numbness. Severe symptoms: severe pain 
or numbness, loss of dexterity, difficulty in 
walking.
Mild to moderate signs: hyper-reflexia, 
Hoffman’s or Babinski’s signs, mild weak-
ness. Severe signs: significant weakness, 
spasticity.
Moderate stenosis: Mid-sagittal diameter: 
10-12 mm. Severe stenosis: Mid-sagittal 
diameter: < 10 mm.
The recommendations are based on the best 
available literature.
This is just a guideline. Cases need to be 
managed individually, based on the whole 
clinical scenario, progression of the disease, 
and co-morbidities.
References
Effect of intramedullary signal changes on the surgical 
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Suri et al. Spine J 2003; 3 (1): 33-45
Laminectomy and posterior cervical plating for multilevel 
cervical spondylotic myelopathy and ossification of the 
posterior longitudinal ligament: effects on cervical align-
ment, spinal cord compression, and neurological outcome. 
Houten J, Cooper P. Neurosurgery 2003; 52 (5): 1081-8
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lotic radiculomyelopathy. Fouyas I, Statham P, Sandercock 
P. Spine 2002; 27 (7): 736-47
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Indications for circumferential surgery for cervical spondy-
lotic myelopathy. Kim P, Alexander J. Spine J 2006; 6 Suppl: 
S 299-307
Surgical management of cervical myelopathy: indications 
and techniques for surgical corpectomy. Medow J, Trost G, 
Sandin J. Spine J 2006; 6 Suppl: S 233-41
Surgical management of cervical myelopathy: indications 
and techniques for laminectomy and fusion. Komotar R, 
Morcco J, Kaiser M. Spine J 2006; 6 Suppl: S 252-67
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ential spondylotic cervical stenosis: review of 50 consecutive 
cases. Sekhon L. J Clin Neurosci 2006; 13 (1): 23-30
Does the treatment of carotid 
dissection require anticoagulation 
with coumadin or is antiplatelet 
therapy equally efficacious?
Aditya Pandey, MD
Vessel dissection represents injury to the wall 
of the vessel either from the luminal side or 
adventitial (outside) side.  Extracranial carotid 
and vertebral artery dissections represent the 
second leading cause of stroke in young adults. 
Its incidence is 2-3 persons/ 100,000/ year. 
The mechanism of developing stroke within 
this patient population is from clot formation 
at the site of the injury to the vessel.  The 
causes of carotid dissection are numerous, but 
it most commonly occurs due to a traumatic 
injury in an individual who has weakened 
vessels. To prevent such an event, patients are 
started on blood thinners: either antiplatelet 
(aspirin) or coumadin.
Depending on physician and surgeon prefer-
ence, different anticoagulation therapy can be 
used for the same type of patient with carotid 
4.
5.
6.
7.
Table 1.  Score System
No Symptoms 0 Mild to Moderate Symptoms 1  Severe Symptoms  2
No Signs 0 Mild to Moderate Signs 1 Severe Signs  2
No stenosis 0 Moderate Stenosis 1  Severe Stenosis  2
No signal changes 0   Signal Changes on MRI 2  
on MRI
Total score 1-3:  Conservative management.  Total score 4-8: Surgery.
http://commons.wikimedia.org/wiki/Image:Blut-EDTA.jpg
3
Andrews MD: Clinical Guidelines Written by Residents
Published by Jefferson Digital Commons, 2009
JHN JOURNAL 
Resident Education
dissection. Those who use coumadin do so 
since they have had success in treating carotid 
dissection patients without stroke formation. 
The same is true of physicians utilizing anti-
platelet therapy. The use of coumadin not only 
requires that patients have frequent blood tests 
to show level of blood thinning but also that the 
bleeding risks associated with it are higher. The 
goal of this analysis is to present the evidence 
for using coumadin versus aspirin in the treat-
ment of carotid dissection. 
Benefits of Full Anticoagulation
anticoagulation leads to the prevention of 
stroke from the formation of clots at the site 
of the vessel injury
Complications of Full Anticoagulation
anticoagulation could lead to further bleed-
ing into the brain
Specifics of Search
Search of National  Clearinghouse 
Guidelines revealed one review but no 
specific guidelines
Search of the Cochrane Database did not 
reveal any position statements on the 
subject
The following key term searches on Pub-
med led to numerous articles on the subject 
of treating carotid dissection with antico-
agulation:
“Extracranial carotid dissection”
“Treatment of extracranial carotid dis-
section”
“Anticoagulation for extracranial carotid 
dissection”
Results
Antithrombotic drugs for carotid artery dis-
section.  Cochrane Database Syst Rev. 2000; 
(4): CD 000255
Strengths
comprehensive review of case controlled 
studies and case series
applies to carotid dissection patients who 
had undergone either anticoagulation 
with coumadin or antiplatelet therapy
Limitations
no randomized control trials included in 
this study (No RCT have been performed 
addressing this issue)
Summary
26 eligible studies were reviewed (327 
patients)
•
•
•
•
•
-
-
-
1.
-
-
-
-
No statistically significant difference in 
outcome (mortality/disability) between 
patients on antiplatelet therapy versus 
those on anticoagulation (coumadin)
No difference in the occurrence of intra-
cerebral hemorrhage between the two 
groups (0% for antiplatelet group and 
0.5% for anticoagulation group)
Conclusion
no statistically significant difference in 
outcome or complication when com-
paring the anticoagulation versus the 
antiplatelet group of patients
Cervical Arterial Dissection: time for a 
therapeutic trial? Stroke. 2003 Dec; 34 (12): 
2856 – 60
Strengths
prospective enrolled patients with carotid 
and vertebral dissections
large number of patients (n=116)
comparison of aspirin vs. anticoagulation
Weaknesses
not a randomized control trial
N might not be large enough to a small 
statistically significant difference
Summary
Canadian Stroke Consortium prospec-
tively enrolled patients with extra-cranial 
dissections and followed patients for 
one year. The endpoints being evalu-
ated included: TIA, Stroke, or Death. 
105 patients had complete follow up. In 
patients treated with anticoagulation the 
event rate was 8.3% versus those treated 
with aspirin where the event rate was 
12.4%. While there was an absolute dif-
ference of 4.1%, this difference was not 
statistically significant.
Conclusion
There were no statistically significant differ-
ences between the outcome rates of patients on 
ASA versus those on anticoagulation.
Dissection of Cervical Arteries: Long-term 
follow-up study of 130 consecutive cases. 
Cerebrovasc Dis. 2006; 22 (2-3): 150-4
Strengths
Prospective Study
N=130 cases
Comparison of ASA vs. anticoagulation
Weaknesses
not a randomized control trial
F/U only 6 months
-
-
-
2.
-
-
-
-
-
-
1.
-
-
-
-
-
Summary
130 patients with angiographically 
proven cervical arterial dissection were 
followed for the events of stroke and 
death. There was no significant differ-
ences in outcome were found when 
comparing patients on aspirin versus 
the patients on anticoagulation.
Conclusion
In patients with proven carotid dissections, 
there is no difference in outcome between 
patients treated with ASA vs. those treated with 
anticoagulation.
Outcome of extracranial cervicocephalic 
arterial dissections: A follow-up study. 
Neurol Res. 2002 Jun; 24 (4): 395-8
Strengths
comparison of ASA vs. anticoagulation
long term f/u (nearly 10 years)
Weaknesses
not a randomized control trial
small patient population (n=27)
Summary
27 patients with extracrainal CAD who 
were treated and followed by the stroke 
service.  Outcome was assessed using the 
modified Rankin Score and recurrent 
stroke and TIAs were also recorded.  The 
outcome was favorable with either anti-
platelet or anticoagulation.
Conclusion
Either antiplatelets or anticoagulation are 
equally effective in preventing strokes after 
carotid dissection,
Final Guideline
In individuals with a proven extracranial 
carotid dissection, aspirin therapy should be 
initiated instead of coumadin. The current 
literature on the subject shows no statistically 
significant difference in outcome of individuals 
treated with aspirin versus those treated with 
coumadin in the setting of carotid dissection. 
While the risks with coumadin are not higher, 
it still requires evaluation of the INR for accu-
rate dosing. Such is not the requirement of 
antiplatelet therapy. In addition other medica-
tions (cimetidine) can affect the metabolism of 
coumadin thus leading to inappropriate levels 
of anticoagulation. Thus antiplatelet therapy is 
an effective method of preventing strokes in 
individuals with carotid dissection. 
-
1.
-
-
-
-
-
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Would a standardized protocol for the 
inter-hospital transport of critically ill 
patients alter outcomes? 
Jack Klem, MD 
The rapid evolution of healthcare technology 
has created a disparity among hospitals and 
thus led to the establishment of highly special-
ized quarternary institutions, termed “Centers 
of Excellence.” This has created a need for the 
systematic triage and transport of certain criti-
cally ill patients that would not receive adequate 
care at a community hospital. Emergency 
Medical Services (EMS) has made the transport 
of patients a national issue due to regionaliza-
tion, specialization, and facility designation 
by payers. Despite this, there exists a paucity 
of guidelines to direct the appropriate flow of 
patients to higher levels of care. 
Diversity exists amongst transport teams 
and overall resource allocation. Interfacility 
transport is provided by a variety of levels and 
types of personnel and agencies. The medical 
condition of the patient is not always matched 
appropriately with the acuity of care provided 
by the transport team. Less severely ill patients 
are sometimes intubated and ventilated solely 
to facilitate ease and safety of transport. 
In addition, the disease process of a particular 
diagnosis is not always understood prior to 
dispatching the appropriate means of transport 
(ie, air vs. ground). For example, patients 
with suspected aneurysmal subarachnoid 
hemorrhage require the most expeditious 
mode of transportation due the high risk of re-
rupture in the acute period. Moreover, certain 
diagnoses such as cerebellar hematoma with 
deteriorating neurological function require 
immediate transfer to the operating room with 
no need for an available ICU bed. Recognition 
of these “hyperacute” scenarios are critical to 
patient outcome. 
Guidelines are necessary to standardize inter-
facility transport on at least the regional level. 
Several steps must be analyzed in order to 
establish a systems-based protocol for inter-
facility transfer. The type of transfer must be 
established (ie, hospital to hospital, rehab to 
hospital, clinic to hospital, etc.) Next, provider 
capabilities must match the patient’s current 
and potential needs in order to provide safe and 
effective care during transport. This has been 
shown to impact outcomes in the transport of 
pediatric patients. On an administrative level, 
certification of necessity for transfer is a require-
ment for reimbursement by Medicare and 
Medicaid. This is directed by federal legislation 
outlined in the Consolidated Omnibus Budget 
Reconciliation Act (COBRA) and Emergency 
Medical Treatment and Labor Act (EMTALA). 
In summary, all of these factors must be inte-
grated in order to develop a regional or even 
national plan for interfacility transport. This 
shall streamline resource allocation and poten-
tially improve outcomes
Online Search
National Guidelines Clearinghouse was 
queried for “patient, hospital transport” and 
“interhospital transport”
Google was queried for “patient transport, 
guidelines” and “hospital transport”
Study #1: Warren at al (00)
Full reference: Warren et al. Guidelines for 
the inter- and intrahospital transport of criti-
cally ill patients. Crit Care Med 32:1 (2004) 
256- 262.
Purpose 
Development of practice guidelines for 
inter- and intrahospital transport of the 
critically ill patient in order to establish 
an efficient, organized process supported 
by appropriate equipment and personnel. 
This would ultimately enhance patient 
safety.
Methods 
Synthesis of prospective clinical outcome 
studies, retrospective reviews, and anec-
dotal reports by a task force of experts 
providing consensus opinion.
Results  
A multidisciplinary team of physicians, 
nurses, respiratory therapists, hospital 
administration and the local emergency 
medical service must justify and coordi-
nate the process by conducting a needs 
assessment of the referring hospital or 
clinic, asking whether transport is likely 
1.
2.
-
-
-
to alter the management or outcome of 
the patient.  A patient must have a pre-
liminary diagnosis that can be further 
refined and ultimately treated at a center 
that offers specialized diagnostic capabil-
ity.  Receiving hospitals should then pro-
ceed with a formalized plan addressing 
the following points:
pretransport coordination and commu-
nication
transport personnel
transport equipment: 
monitoring during transport
documentation: The patient’s medi-
cal record and relevant laboratory and 
radiographic studies must be copied for 
the accepting facility. It is also suggested 
to perform a COBRA/EMTALA check-
list to ensure compliance with federal 
regulations. 
The above five points should be evalu-
ated and refined regularly by the hospital 
using a standard quality improvement 
process. Many of the specific details from 
these guidelines are incorporated in the 
final guidelines below.
Conclusions 
When services are required that exceed avail-
able resources at a particular hospital or clinic, 
a patient will be ideally transferred to a facility 
that has the necessary resources. The decision 
to transport a critically ill patient is based on 
the potential benefits (ie, higher level of tech-
nical/cognitive/procedural care) and weighed 
against the risks. Justification for transport 
must be established and several points must 
be addressed to ensure safe and efficient 
transfer.  
Strengths of study
Article provides clear, comprehensive 
guidelines discussed above for transport-
ing patient within and between hospitals. 
Not only do these guidelines comply with 
federal regulations, but they also illustrate 
the importance of having an organized, 
efficient and standardized protocol that 
can be followed by any hospital.
Details of transport such as appropriate 
equipment and personnel are described 
in order to ensure utmost safety for the 
patient being transported. Again, this is 
an effort to standardize the entire process 
in order to eliminate “system-based” 
mistakes. For example, there exists much 
variability in the acuity of care provided 
-
-
-
-
-
-
-
-
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by transport teams due to improper 
triage, insufficient equipment, and 
inexperienced personnel. To resolve this, 
this article takes the stance that patient 
transportation must be subjected to the 
same rigors as the aviation industry in 
eliminating systems errors by establishing 
a universal set of guidelines.
Weaknesses of study
This is really the first effort in the literature 
to establish a universal set of guidelines 
and, as a result, no outcome studies are 
yet available. 
This article also assumes that every hospi-
tal has the same basic resources available 
to standardize patient transport. This 
becomes an issue with the transport of 
critically ill patients where the accepting 
hospital may have to provide the appro-
priately staffed and equipped transporta-
tion team.    
Study #: Fan et al (00)
Full reference: Fan et al. Outcomes of inter-
facility critical care adult patient transport: a 
systematic review. Critical Care 10 (2006) 1-7.
Purpose 
Determine the adverse events and impor-
tant prognostic factors associated with 
interfacility transport of intubated and 
mechanically ventilated adult patients.
Methods 
A systematic review of multiple databases 
yielded 5 case-series comprising of a total 
of 245 patients. Two of the case-series 
were prospective in design.
Results 
Data was synthesized in a qualitative 
manner due to significant heterogeneity 
in study population, outcome events, and 
results. The most common indication for 
interfacility transport was a need for spe-
cialized investigations and interventions. 
Transport modalities included air (66%), 
ground (31%) and commercial aircraft 
(3%). Transport teams included a physi-
cian in 3 of the 5 studies. Death during 
transport was rare (n=1) and no other 
adverse events or significant therapeutic 
interventions were reported during 
transport. Of note, one study reported 
a 19% (28/145) incidence of respiratory 
alkalosis upon arrival.
-
-
-
-
-
-
Conclusion 
Insufficient data exists regarding the mortality, 
morbidity, and risk factors associated with the 
interfacility transport of critically ill patients. 
Further research is necessary to understand 
which patients are most at risk while being 
transported. Recognizing the types of events 
that can occur is an important step in patient 
preparation and planning.
Strengths of study
First attempt to study outcomes of inter-
hospital transport of critically ill patients 
Weaknesses of study
This is similar to a meta-analysis that 
combines different levels of evidence 
(ie, three retrospective studies plus two 
prospective studies) and attempts to draw 
meaningful conclusions. There must be 
one prospective trial that addresses the 
same patient population.
This article looks only at adverse out-
comes that occur while a patient is en 
route rather than considering the period 
just before and after transport. This under 
reports situations, for example, where 
some patients begin to deteriorate and 
are intubated immediately upon arrival.
Study #: Ligtenberg et al (00)
Full reference: Ligtenberg et al. Quality of 
interhospital transport of critically ill patients: 
a prospective audit. Critical Care 9 (2005)  
446-51.
Purpose 
Determine the adverse events and impor-
tant prognostic factors associated with 
interfacility transport.
Methods 
prospective study describing 100 con-
secutive ICU transfers, of which 65% 
were mechanically ventilated and 38% 
on vasoactive drugs. 
Results 
Data was collected on adverse events 
before, during, and after transport. 34% 
of patients incurred adverse events with 
6 deaths being reported within the first 
24-hours after arrival. This study was 
different because not all patients were 
intubated and not all were accompanied 
by a physician as was the case in Fan et 
al. (2006). 
-
-
-
-
-
-
Conclusions 
Important factors for improvement were better 
overall communication between the refer-
ring/ receiving hospital and strict adherence to 
checklists/ published protocols.
Strengths of study
Describes a single, prospective study 
involving the transfer of 100 patients into 
only one university center. This elimi-
nates the inherent flaws of a combining 
several different studies.
Information regarding adverse events 
was collected for 24-hours after arrival. 
Weaknesses of study
There was no stratification of diagnoses. 
For example, there is no discussion as 
to why each of the 34 adverse events 
occurred. For example, was this due to 
inadequate stabilization of the patient’s 
medical condition prior to transport, 
due to inadequate care provided during 
transport, or merely patient disease?
Final Guidlines for inter-hospital transport of 
critically ill patients
Diagnosis 
Patient requires emergent surgical inter-
vention that will occur immediately upon 
arrival to the accepting institution. This 
applies to diagnoses such as cerebellar 
hematoma, EDH, or SDH in the setting 
of a rapidly deteriorating patient. This 
defines the highest acuity transfer wherein 
communication between physicians, OR 
staff, and transport personnel is critical to 
transporting a patient directly to the hold-
ing area and/or operating room in order 
to save the patient’s life. Expending time 
to “make a bed” at the accepting institu-
tion will gravely impact the patient’s 
outcome and thus must be overlooked in 
order to transport the patient as rapidly as 
possible to the operating suite. 
Patient requires emergent surgical 
intervention within 24-hours of arriving 
to the accepting institution. This applies 
to diagnoses such as SAH where cerebral 
angiogram with definitive treatment is 
performed within 24-hours of arrival. 
The caveat here is that these patients may 
develop hydrocephalus which sometimes 
cannot be treated at a referring institution 
and therefore requires emergent trans-
port. Another diagnosis is cauda equina 
where a patient will require an MRI fol-
lowed by surgery within 24-hours.
-
-
-
-
-
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Patient requires urgent imaging stud-
ies that may or may not require surgery 
in the setting of a neurologically and 
medically stable patient. This applies to 
diagnoses such as cervical spine trauma 
where the patient’s neurological status 
is not changing. For example, a patient 
with facet dislocation requiring traction 
and/or reduction.
Patient requires observation in a 
neurosurgical ICU, but remains stable 
neurologically. This applies to diagnoses 
such as a basal ganglia hemorrhage.
Patient does not have an established 
diagnosis due to lack of MRI, angiogra-
phy, etc. at the referring institution but 
remains neurologically stable. 
PRE-TRANSPORT COORDINATION 
Communication is Key 
Establish continuity of care by physi-
cian-to-physician and nurse-to-nurse 
review of patient condition and current 
treatment plan. Receiving physician 
should provide advice to aid in pretrans-
port stabilization and provide advance 
medical treatment when appropriate (ie, 
Mannitol, steroids, antiepileptic in setting 
of aneurysmal SAH with hydrocephalus). 
The appropriate arrangements should 
be made at the receiving institution to 
avoid delays in definitive treatment (ie, 
operating room standby). The mode 
of transport must also be established. 
Communication is especially critical in 
the setting of the first set of diagnoses 
described above.
TRANSPORT PERSONNEL
Education = Empowerment to Intervene
A minimum of two people should accom-
pany a critically ill patient consisting of a 
critical care nurse plus a technician. In the 
case of an unstable patient, it is recom-
-
-
-
-
-
mended that a physician with training in 
airway management and ACLS be pres-
ent. When this is not possible, some 
hospitals prophylactically intubate those 
patients who have a high risk for becom-
ing unstable en route. In the setting of 
elevated ICP, the transport personnel 
must understand the diagnosis and 
means of controlling ICP during trans-
port. For example, most patients arrive 
flat and supine which is not the optimal 
position for a patient with impending 
hydrocephalus. Transport personnel 
cannot serve as technicians, but must be 
aware of the patients diagnosis in order 
to best maintain and even optimize the 
patient prior to arrival. 
TRANSPORT EQUIPMENT
Continuity of Care
The patient must be maintained using the 
same monitors and drugs (if necessary) 
as are present in the ICU. A blood pres-
sure monitor, pulse oximeter, cardiac 
monitor/ defibrillator, basic rescucitation 
drugs, and a portable mechanical ventila-
tor when indicated.  
DOCUMENTATION:
What is the Goal of Transfer? 
The patient’s medical record and 
relevant laboratory and radiographic 
studies must be copied for the accepting 
facility. It is also suggested to perform a 
COBRA/EMTALA checklist to ensure 
compliance with federal regulations. This 
includes documentation of initial medical 
evaluation and stabilization procedures, 
informed consent disclosing risks and 
benefits of transfer, and documentation 
of physician-to-physician communica-
tion with the names of each physician 
involved. Financially motivated transfers 
are illegal. 
-
-
 The above five points serve as a gen-
eral set of guidelines that should be 
evaluated and refined regularly by 
the hospital using a standard quality 
improvement process. The hospital 
transfer center should develop a check-
list for each of the five points described 
above and follow the same steps for each 
and every transfer. Attention to details 
by methodically following the same 
steps in each situation will hopefully 
minimize “systems” mistakes and thus 
not only improve efficiency, but also 
maximize safety.
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